Inc. Magazine Ranks SynCardia Systems in Top 3rd in its 2014 Inc. 5000 List
The Tucson Company manufactures the Total Artificial Heart, the world’s only approved device that eliminates the source of end-stage biventricular failure, and the Freedom portable driver.
TUCSON, Ariz. – Aug. 26, 2014 – SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, is high on the Inc. 5000 named by the business magazine Inc.
“SynCardia manufactures the world’s only FDA, Health Canada and CE approved Total Artificial Heart, which is used as a bridge to a matching donor heart transplant,” says Michael P. Garippa, SynCardia’s CEO and President. “It has become the standard of care for patients dying from end-stage biventricular heart failure.”
This year the business magazine ranked SynCardia 137th among 377 companies in the health industry and number 1,698 on the list of 5,000 companies. The privately held Tucson-based firm also was ranked 34th among 104 fastest growing companies in Arizona.
The 2014 rankings put SynCardia around the top third in the list.
This is the fourth time SynCardia has made the Inc. 5000 list. It rose from a ranking of 3,136th place in 2011, showing a 46% improvement in this year’s ranking.
The company also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to wait for matching donor hearts at home and in their community. Patients, hospitals and insurance companies can save thousands of dollars of in-hospital costs for this portion of patient care.
- Like SynCardia on Facebook
- Follow SynCardia on Twitter @SynCardia
- Connect with SynCardia on LinkedIn
- Share and Discover on Google+
About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.
Janelle Drumwright, email@example.com, (520) 547-7463